Research

The urgency of research into meningitis and encephalitis

Meningitis and encephalitis are serious, often fatal diseases that are difficult to recognize and can worsen quickly. Without rapid treatment, there is a risk of lasting brain damage or death. Better diagnostics and treatment are urgently needed. Scientific research is therefore of great importance: the sooner we understand the disease, the faster life saving treatments can be developed.

Our contribution to research: collaboration and financial support

We accelerate medical research by connecting leading scientists and institutions worldwide. At this moment, seven universities from countries including the Netherlands, the United Kingdom, Italy, Sweden, and the United States are working together. This collaborative effort allows knowledge and breakthroughs to be achieved faster.

Research depends on financial support. We raise funds to make research possible and seek collaboration with co investors such as the Vermas Foundation and the W.M. de Hoop Foundation.

All of this contributes to one goal: to accelerate and expand scientific medical research for breakthroughs in the diagnosis, treatment, and fight against meningitis and encephalitis.  

Ongoing research

Image

Rapid test for viral meningitis and viral encephalitis

Amsterdam UMC under the supervision of Matthijs Brouwer
The research is based on the analysis of cerebrospinal fluid from many patients in whom doctors suspect a brain infection.
Image

Global Care Gaps in Autoimmune Encephalitis

Top specialists from the Netherlands, Germany and the United States
Global Care Gaps in Autoimmune Encephalitis (AIE) focuses on faster recognition, more effective treatment , and better support for patients during their recovery.
Image

Identifying new viral causes of encephalitis using VirScan technology

Collaboration between research teams from Harvard Medical School and Amsterdam UMC
With VirScan, more than 1,000 viruses can be identified in serum from patients taken 6 weeks after infection, through the binding of antibodies to bacteriophages followed by DNA sequencing.
Image

Prevention and treatment of meningitis caused by Group B streptococci

Team Amsterdam UMC in collaboration with the Wellcome Sanger Institute under the supervision of Dr. Merijn Bijlsma
The study examines whether targeted prevention and treatment of meningitis caused by Group B streptococci, GBS, is possible by testing for GBS virulence genes.
Image

New antibodies that cause encephalitis or influence its severity

Team Erasmus MC under the supervision of Dr Maarten Titulaer
In this study, the team applies the new HuScan technique in patients with autoimmune encephalitis, with or without previous viral encephalitis, to identify new antibodies that cause or influence the disease.
Image

Role of Covid 19 related autoantibodies in pneumococcal meningitis

Team Amsterdam UMC in collaboration with the National Institutes of Health, USA, under the supervision of Prof. Dr. Diederik van de Beek
Research into whether the same Covid 19 mechanism of neutralizing autoantibodies could be at work in patients with pneumococcal meningitis.
Image

Recovery after encephalitis: a new chance for children

Team Sophia Children's Hospital, led by Juliette Brenner, Maarten Titulaer, and Rinze Neuteboom.
Sophia Children’s Hospital is not only a hospital, but also an academic world where patient care, research, and education come together. A place where children truly come first. Also for meningitis and encephalitis.

Completed research

Image

Molecular mechanisms of neuronal damage caused by pneumococcal infections in the brain

Team Karolinska Institutet under the supervision of Associate Professor Dr. Federico Lovino
The research aims to develop new therapeutic approaches that interfere with these mechanisms by blocking bacteria neuron interaction, in order to protect neurons from injury caused by bacterial interaction.
Image

Identifying new pathogenic antibodies that lead to autoimmune encephalitis

Team Human Technopole in collaboration with Erasmus MC under the supervision of Dr. Oliver Harschnitz
The research focuses on developing and applying advanced human stem cell–based models of the brainstem to identify novel pathogenic antibodies that lead to autoimmune encephalitis.
Image

How antibiotics work in cerebrospinal fluid: an important milestone in meningitis research

Team Amsterdam UMC in collaboration with UC San Diego under the supervision of Prof. Dr. Nina van Sorge
The study shows that commonly used antibiotics may be less effective in cerebrospinal fluid than laboratory tests suggest, highlighting the need for better and more realistic testing methods to determine the right medication more quickly.
Image

Dysregulated immune response makes meningitis more severe

Researchers from Amsterdam UMC led by Prof. Dr. Diederik van de Beek
New insights into why some people become more severely ill from a pneumococcal infection. The findings open new avenues for research into personalized infection risk and targeted immune therapies.
Quote

Donate

These research projects are only possible thanks to donations

Meningitis or encephalitis can happen to anyone. They’re invisible, unpredictable diseases that change lives forever. For those affected, the struggle can be long, difficult, and full of uncertainty. But there is hope.

Help us take away uncertainty and offer a future full of hope. ItsME Foundation is here for everyone who fights these diseases together. ItsME is for everyone fighting this disease together. 

Donate today, because every contribution counts. Your support helps us with:

  • Research into better diagnosis and faster treatment
  • Raising awareness, including among doctors and medical professionals
  • Support for those affected and their families